Business News
RSS/Syndication
Search
Ranbaxy Laboratories
Plot 90, Sector 32
Gurgaon, Haryana, IND
Company Profile
About Ranbaxy Laboratories
Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company’s foray into Novel Drug Delivery Systems has led to proprietary "platform technologies", resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 9 countries.
For more information, visit www.ranbaxy.com.
Contact Persons
Recent press release
The deal is valued at R500 million (USD 70 Million) and will make Ranbaxy the fifth largest generic pharmaceutical company in South Africa....
Operating profit before tax doubles (Rs 1,597 Mn, up 100%); Consolidated Revenues at Rs.15,644 Mn; up 23% compared to corresponding quarter....
Ranbaxy granted 180 days exclusivity for 80mg dosage...
Following an inspection conducted by the National Agency of Medicine, the Bucharest based production facility of Terapia Ranbaxy has received a renewal of certification for Good Manufacturing Practice standards at the operational level....
Board approves 2nd interim dividend of 120% taking total dividend for 2006 to 170%...
